BOZE
BOZE
08.jpg

About Founder

Professor Yu Hongru is the founder of BOZE FO, an expert in medicine and biochemistry, and a knowledgeable entrepreneur in high-tech who started technical innovation from the university laboratory.

Professor Yu Hongru has led a number of research and successfully developed several vital products including the "Deproteinized Calf Blood Serum Injection" and the "Hemocoagulase For Injection” whose sales rank at the forefront of domestic clinical medicine. He also founded the domestically renowned bio-pharmaceutical company - Jinzhou Aohong Pharmaceutical, and successfully carried out the industrial upgrading, making a big fortune. In Beijing, he established the BOZE FO, and with the “spirit of the craftsman”, he meticulously leads the team and spares no efforts to make BOZE the pioneer in Chinese-featured private MFO during times of industrial transformation and upgrading!

Corporate Culture

Spirit
The grace of men of virture can long last to future generations.
Vision
To be a pioneer in the Chinese private multi-family offices during times of industrial transformation and upgrading.
Mission
To provide modern systematic wealth management and succession solutions for wealthy families.
Values
people-oriented approach, innovation, constant improvement, stronger families for a stronger nation.

Securities Investment

BOZE FO has been developing the global asset allocation method since 2013 following the investment philosophy that integrates western classical asset allocation ideas, Chinese characteristics and the company’s strengths. As a pioneer in family office asset management in China, BOZE has gained rich experience in domestic and foreign investment……

Equity Investment

BOZE’s founding family earned its assets from the pharmaceutical industry. With the long-term, stable, and responsible investment philosophy, BOZE family office combines the characteristics of pharmaceutical with diversified industry strategies, sets its sights on long-term value, and takes investment in optimal sub-funds as the core strategy……

Investment Research System

The investment research system of BOZE is composed of talented financial investors and pharmaceutical experts. The system now contains over 20 members, and the investment managers have an average investing experience of over 15 years in domestic and international large, non-private funds or in the pharmaceutical industry. The pharmaceutical expert team shows a deep understanding of domestic pharmaceutical industry policies, and can spot investment value from an industrial perspective. The asset allocation expert team is made up of accomplished people in the field who have years of practice in global asset allocation.